Long-term outcomes of eltrombopag plus cyclosporine A in eltrombopag-exposed patients with glucocorticoid-resistant or -dependent primary immune thrombocytopenia: a prospective, multicenter, single-arm, phase II study with extended follow-up.

cyclosporin A microemulsion - Generic mfg.

Promacta (eltrombopag) - Novartis

http://www.ncbi.nlm.nih.gov/pubmed/42780154

Changle Huang; Fangqi Cheng; Huifang Jiang; Jiayue Qin; Jie Jin; Jin Lai; Lihong Cao; Xuwei Shao; Yuhui Yuan

Sep 25, 2026